You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
  1. CORPORATE - 19-04-2017

    Kedrion Biopharma signs agreement with European Hemophilia Consortium (EHC)

    The agreement aims to improve patient access to coagulation disorders treatments in Europe

    read more 
  2. CORPORATE - 24-03-2017

    New company AO Kirov Plasma established in Russia

    It’s a joint venture between Kedrion Biopharma, Nacimbio and Pharmastandard

    read more 
  3. Kedrion - Feature thumbnail

    CORPORATE - 28-12-2016

    Kedrion Biopharma strengthens its presence in Russia

    Memorandum of Understanding with Russian pharmaceutical companies for a joint plasma products manufacturing program

    read more 
  4. CORPORATE - 17-06-2016

    Kedrion Biopharma consolidates presence on Russian market

    Joint venture with Nacimbio of RosTECH group for a technology transfer to Kirov plant

    read more 

Pages

For more information please contact: pressoffice@kedrion.com